PT96789B - Processo de preparacao de um medicamento a base de lisados bacterianos - Google Patents

Processo de preparacao de um medicamento a base de lisados bacterianos Download PDF

Info

Publication number: PT96789B
Authority: PT; Portugal
Prior art keywords: nctc; bacterial; lysate; bacterial lysate; process according
Prior art date: 1990-02-16

Application number

PT96789A

Other languages

English (en)

Portuguese (pt)

Other versions

PT96789A (pt

Inventor

Jean-Claude Farine

Alfred De Courten

Original Assignee

Om Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-16

Filing date

1991-02-15

Publication date

1998-08-31

1991-02-15 Application filed by Om Lab Sa filed Critical Om Lab Sa

1991-10-31 Publication of PT96789A publication Critical patent/PT96789A/pt

1998-08-31 Publication of PT96789B publication Critical patent/PT96789B/pt

Links

239000003814 drug Substances 0.000 title claims abstract description 22
230000001580 bacterial effect Effects 0.000 title claims abstract description 19
238000002360 preparation method Methods 0.000 title claims description 7
229940079593 drug Drugs 0.000 title abstract description 12
239000006166 lysate Substances 0.000 claims abstract description 21
206010012438 Dermatitis atopic Diseases 0.000 claims abstract description 13
201000008937 atopic dermatitis Diseases 0.000 claims abstract description 13
241000588747 Klebsiella pneumoniae Species 0.000 claims abstract description 5
241000588744 Klebsiella pneumoniae subsp. ozaenae Species 0.000 claims abstract description 5
241000588653 Neisseria Species 0.000 claims abstract description 5
241000191967 Staphylococcus aureus Species 0.000 claims abstract description 5
241000193998 Streptococcus pneumoniae Species 0.000 claims abstract description 5
241000606768 Haemophilus influenzae Species 0.000 claims abstract description 4
241000588655 Moraxella catarrhalis Species 0.000 claims abstract description 4
241001312524 Streptococcus viridans Species 0.000 claims abstract description 4
229940047650 haemophilus influenzae Drugs 0.000 claims abstract description 3
238000000034 method Methods 0.000 claims description 8
239000002775 capsule Substances 0.000 claims description 7
241000193996 Streptococcus pyogenes Species 0.000 claims description 3
239000001963 growth medium Substances 0.000 claims description 3
239000000203 mixture Substances 0.000 claims description 2
241000894006 Bacteria Species 0.000 claims 2
238000004519 manufacturing process Methods 0.000 abstract description 3
108060003951 Immunoglobulin Proteins 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
239000012141 concentrate Substances 0.000 description 4
102000018358 immunoglobulin Human genes 0.000 description 4
229940072221 immunoglobulins Drugs 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
244000052616 bacterial pathogen Species 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000008103 glucose Substances 0.000 description 3
239000002609 medium Substances 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
208000035473 Communicable disease Diseases 0.000 description 2
201000004624 Dermatitis Diseases 0.000 description 2
231100000111 LD50 Toxicity 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
208000003251 Pruritus Diseases 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
229940041514 candida albicans extract Drugs 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
210000002345 respiratory system Anatomy 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000012138 yeast extract Substances 0.000 description 2
CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
239000004251 Ammonium lactate Substances 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
206010024438 Lichenification Diseases 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
239000013566 allergen Substances 0.000 description 1
229940059265 ammonium lactate Drugs 0.000 description 1
235000019286 ammonium lactate Nutrition 0.000 description 1
RZOBLYBZQXQGFY-HSHFZTNMSA-N azanium;(2r)-2-hydroxypropanoate Chemical compound [NH4+].C[C@@H](O)C([O-])=O RZOBLYBZQXQGFY-HSHFZTNMSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000007969 cellular immunity Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000011443 conventional therapy Methods 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
238000011118 depth filtration Methods 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000000951 immunodiffusion Effects 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
230000007803 itching Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229940005581 sodium lactate Drugs 0.000 description 1
239000001540 sodium lactate Substances 0.000 description 1
235000011088 sodium lactate Nutrition 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
235000019157 thiamine Nutrition 0.000 description 1
JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
239000011721 thiamine Substances 0.000 description 1
231100000820 toxicity test Toxicity 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Mycology (AREA)
Microbiology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)

PT96789A 1990-02-16 1991-02-15 Processo de preparacao de um medicamento a base de lisados bacterianos PT96789B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH497/90A CH680045A5 (fr)	1990-02-16	1990-02-16

Publications (2)

Publication Number	Publication Date
PT96789A PT96789A (pt)	1991-10-31
PT96789B true PT96789B (pt)	1998-08-31

Family

ID=4188357

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96789A PT96789B (pt)	1990-02-16	1991-02-15	Processo de preparacao de um medicamento a base de lisados bacterianos

Country Status (13)

Country	Link
JP (1)	JP3002552B2 (fr)
KR (1)	KR0169982B1 (fr)
AT (1)	AT402152B (fr)
BE (1)	BE1005589A3 (fr)
CH (1)	CH680045A5 (fr)
DE (1)	DE4104728C2 (fr)
EG (1)	EG19540A (fr)
FR (1)	FR2658419B1 (fr)
GB (1)	GB2240922A (fr)
HU (1)	HU210834B (fr)
IT (1)	IT1244743B (fr)
PL (1)	PL289084A1 (fr)
PT (1)	PT96789B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2098109C1 (ru) *	1996-09-26	1997-12-10	Александр Григорьевич Чучалин	Противоаллергическое, противовоспалительное средство, способ его получения, лечебное и косметическое средства с его использованием
WO1999048510A1 (fr) *	1998-03-24	1999-09-30	Tayca Corporation	Inhibiteur de la production d'anticorps d'immunoglobuline m et medicament contre la polyarthrite rhumatoide
WO2004112833A1 (fr)	2003-06-23	2004-12-29	Biotech Tools Sa	Composition d'epitope pour administration par voie sublinguale, buccale ou enterale, obtenue par hydrolyse de structures antigeniques a l'aide de chymotrypsine
UA72065C2 (en) *	2004-09-10	2005-01-17	Viridans Ltd Liability Company	Strain aerococcus viridans 167k imb b-7069 with antibacterial activity and "viabac" preparation comprising this strain
FR2969657B1 (fr)	2010-12-22	2014-02-07	Fabre Pierre Dermo Cosmetique	Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
GB201318170D0 (en) *	2013-10-14	2013-11-27	Univ Edinburgh	Proteins with Diagnostic and Therapeutic Uses
KR102437436B1 (ko)	2019-04-26	2022-08-30	주식회사 엠디헬스케어	스트렙토코커스 파이오제네스 세균 유래 단백질 및 이의 용도
EP3960191A4 (fr) *	2019-04-26	2023-01-04	MD Healthcare Inc.	Protéine dérivée de la bactérie streptococcus pyogenes, et utilisation associée

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH633188A5 (fr) *	1978-05-26	1982-11-30	Om Laboratoires Sa	Medicament contre des maladies infectieuses des voies respiratoires.

1990
- 1990-02-16 CH CH497/90A patent/CH680045A5/fr not_active IP Right Cessation
1991
- 1991-02-13 KR KR1019910002437A patent/KR0169982B1/ko not_active Expired - Fee Related
- 1991-02-14 IT ITMI910381A patent/IT1244743B/it active IP Right Grant
- 1991-02-14 EG EG9191A patent/EG19540A/xx active
- 1991-02-15 HU HU91511A patent/HU210834B/hu not_active IP Right Cessation
- 1991-02-15 GB GB9103278A patent/GB2240922A/en not_active Withdrawn
- 1991-02-15 BE BE9100144A patent/BE1005589A3/fr active
- 1991-02-15 PT PT96789A patent/PT96789B/pt not_active IP Right Cessation
- 1991-02-15 PL PL28908491A patent/PL289084A1/xx unknown
- 1991-02-15 JP JP3022109A patent/JP3002552B2/ja not_active Expired - Lifetime
- 1991-02-15 AT AT0032291A patent/AT402152B/de not_active IP Right Cessation
- 1991-02-15 DE DE4104728A patent/DE4104728C2/de not_active Expired - Fee Related
- 1991-02-15 FR FR9102058A patent/FR2658419B1/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FR2658419A1 (fr)	1991-08-23
EG19540A (en)	1995-08-30
FR2658419B1 (fr)	1995-01-27
IT1244743B (it)	1994-08-08
HU210834B (en)	1995-08-28
HUT61201A (en)	1992-12-28
BE1005589A3 (fr)	1993-11-16
ITMI910381A1 (it)	1992-08-14
ATA32291A (de)	1996-07-15
KR0169982B1 (ko)	1999-02-01
PT96789A (pt)	1991-10-31
DE4104728A1 (de)	1991-08-22
JPH04211017A (ja)	1992-08-03
AT402152B (de)	1997-02-25
ITMI910381A0 (it)	1991-02-14
JP3002552B2 (ja)	2000-01-24
KR910015306A (ko)	1991-09-30
GB9103278D0 (en)	1991-04-03
GB2240922A (en)	1991-08-21
CH680045A5 (fr)	1992-06-15
HU910511D0 (en)	1991-09-30
DE4104728C2 (de)	1999-01-14
PL289084A1 (en)	1991-11-04

Legal Events

Date

Code

Title

Description

1991-10-31

BB1A

Laying open of patent application

Effective date: 19910702

1998-08-31

FG3A

Patent granted, date of granting

Effective date: 19980520

2001-03-30

MM3A

Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20001130

Publication	Publication Date	Title
Whitby	1938	Chemotherapy of bacterial infections
Bryan et al.	1986	Problems in salmonellosis: rationale for clinical trials with newer β-lactam agents and quinolones
US4657763A (en)	1987-04-14	Combined chrysotherapeutic agents for autoimmune diseases
CH672072A5 (fr)	1989-10-31
Long et al.	1937	Observations upon the experimental and clinical use of sulphanilamide in the treatment of certain infections
Daum et al.	1981	Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b
KR0169982B1 (ko)	1999-02-01	피부염 치료용 약제
ROBERTS et al.	1961	Demethylchlortetracycline and Tetracycline: A Critical Comparison: In Vitro Activity, Serum Concentrations, and Effect of Serum Binding
HU180005B (en)	1983-01-28	Process for producing pharmaceutical composition utilizable for treating illnesses of respiratory organs
HU193217B (en)	1987-08-28	Process for producing active agents for immunemodulator compositions
WO2005102320A1 (fr)	2005-11-03	Medicament pour traiter des infections virales
Chauhan et al.	1970	Berberine in the treatment of childhood diarrhoea
Chang et al.	1950	The hypotensive action of influenza virus on rats
Simons	1914	Critical review: Bacterial endocarditis
AU577941B2 (en)	1988-10-06	Non-adjuvenated vaccine
Pines et al.	1973	A comparison of pivampicillin and ampicillin in exacerbations of chronic bronchitis
CN101485757B (zh)	2011-05-04	一种治疗小儿外感发热的中药组合物及其制备方法
CN101816721B (zh)	2012-07-04	一种治疗小儿外感发热的中药组合物及其制备方法
JPH0255407B2 (fr)	1990-11-27
JPH10236956A (ja)	1998-09-08	免疫賦活剤
Fortescue-Brickdale	1903	Collargol: A review of some of its clinical applications, with experiments on its antiseptic action
RU2218927C1 (ru)	2003-12-20	Способ лечения острых кишечных инфекций
Bennion et al.	1992	The use of single-agent antibacterial regimens in the treatment of advanced appendicitis with peritonitis
CN1939325B (zh)	2010-04-14	新鱼腥草素钠和黄芩苷的药物组合物及其制备方法和用途
JPS6239521A (ja)	1987-02-20	免疫増強剤